Limberakis Anthony MD - PA Philadelphia, Philadelphia 19115

Limberakis Anthony MD entered the industry of Doctors in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Doctors. The business provides service to the B2C market.

To acquire more information, please contact Anthony Limberakis by calling (215) 676-5100 during business hours. You can also write to the business’ Single Location at 9601 Bustleton Avenue, Philadelphia, Pennsylvania PA 19115. You can also visit the company’s website at bustletonradiology.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Limberakis Anthony MD
Representative: Anthony Limberakis
Place of Business: 9601 Bustleton Avenue, Philadelphia, PA 19115
Contact Number: (215) 676-5100
Website: bustletonradiology.com
Type of Service: Doctors
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2001
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Limberakis Anthony MD is a company operating from Philadelphia, Pennsylvania providing professional Doctors and relevant B2C variables. It was founded in 2001 and registered with the SIC code 8011 as Doctors, and with the NAICS code 6211110 as Doctors.

With a current employee count of 1 to 4, Limberakis Anthony MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Anthony Limberakis at (215) 676-5100 for related queries, or to locate its Single Location using the coordinates 40.087825,-75.034957.

The Single Location can also be found at the street address 9601 Bustleton Avenue in Philadelphia, Pennsylvania 19115 and can be engaged online through the company website at bustletonradiology.com, the company Twitter , and Facebook page .